UNII 7YIN7J07X4
TREHALOSE DIHYDRATE
UNII Information
- Unique Ingredient Identifier: 7YIN7J07X4
- The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
- Formula: C12H22O11.2H2O
- Molecular Formula, total atoms represented as a molecular structure in a UNII description.
- Preferred Substance Name: TREHALOSE DIHYDRATE
- The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
- InChIKey: DPVHGFAJLZWDOC-PVXXTIHASA-N
- The InChIKey to a unique identifier for a specific substance or ingredient that is based on its molecular structure. InChIKey stands for International Chemical Identifier Key and is a fixed-length string created from the IUPAC International Chemical Identifier (InChI). The InChIKey is useful in drug development and chemical analysis, where the molecular structure of a substance is an important factor in determining its properties and effects.
- SMILES: [C@H]1([C@H](O[C@@H]([C@@H]([C@H]1O)O)O[C@@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[H])CO)O.O.O
- The Simplified Molecular Input Line Entry System or SMILES is a format used to represent and describe the molecular structure of a substance or ingredient. SMILES uses a series of alphanumeric characters to represent the atoms and bonds in a molecule in conjunction with other symbols and operators to indicate the arrangement and connectivity of the atoms.
- Registry Number: 6138-23-4
- The Registry Number is the unique numerical identifiers assigned to a substance or ingredient by the Chemical Abstracts Service (CAS). The CAS registry number is a used and recognized standard identifier by many industries and regulatory agencies. The Registry Number facilitates cross-referencing substances between different databases that may use different naming conventions or identifiers.
- NCI Thesaurus Concept Code: C87706
- The NCI Thesaurus give reference terminology for many systems. The code includes vocabulary for clinical care, translational research, basic research, public information and administrative activities.
- UNII to RxNorm Crosswalk: 1311372 (RXCUI)
- The RxNorm Ingredient Concept Code is the numeric code assigned to a specific substance or ingredient by the National Library of Medicine's RxNorm system. By including the RxNorm code in the UNII code system it is possible to crossover UNII codes to RxNom.
- PubChem Compound ID: 181978
- The PubChem Compound ID is a unique identifier for a specific substance or ingredient in the PubChem database which is the largest collection of freely accessible chemical information by the National Center for Biotechnology Information. The PubChem database is a resource for drug discovery, development, chemical research, and other applications.
- Ingredient Type: INGREDIENT SUBSTANCE
- Substance Type: 1f9b8861-9f3e-4127-90f8-57a2b284b772
- The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.
UNII Synonyms and Mappings
The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.
- .ALPHA., .ALPHA.-TREHALOSE DIHYDRATE - Common Name
- .ALPHA.-D-GLUCOPYRANOSYL-.ALPHA.-D-GLUCOPYRANOSIDE DIHYDRATE - Common Name
- D-TREHALOSE DIHYDRATE - Common Name
- FEMA NO. 4600 - Code
- MYCOSE DIHYDRATE - Common Name
- TREHALOSE DIHYDRATE - Common Name
- TREHALOSE DIHYDRATE [EP MONOGRAPH] - Common Name
- TREHALOSE DIHYDRATE [MI] - Common Name
- TREHALOSE DIHYDRATE [WHO-DD] - Common Name
UNII Resources
- Common Chemistry
- CAS Common Chemistry is an open community resource of the American Chemical Society for accessing chemical information. The chemical information in the CAS database is curated by expert scientists and includes information of common and frequently regulated chemicals and information applicable to high school and undergraduate chemistry classes.
- Inxight Drugs
- The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
- DailyMed Regulated Products
- The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
- NCATS GSRS Full Record
- The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.
- NCI Thesaurus
- NCI Thesaurus (NCIt) by the National Cancer Institute provides reference terminology for clinical care, translational and basic research, and public information and administrative activities.
- PubChem
- The PubChem database by the National Library of Medicine includes the chemical structures of small organic molecules and information on their biological activities.
UNII Crossover to NDC Codes
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0078-0639 | Proprietary Name: Cosentyx | Secukinumab | Injection | Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-1056 | Proprietary Name: Cosentyx | Secukinumab | Injection | Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | |
0173-0896 | Proprietary Name: Blenrep | Glaxosmithkline Llc | |||||
0310-1730 | Proprietary Name: Fasenra | Benralizumab | Injection, Solution | Subcutaneous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-1830 | Proprietary Name: Fasenra | Benralizumab | Injection, Solution | Subcutaneous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-3040 | Proprietary Name: Saphnelo | Anifrolumab-fnia | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-4500 | Proprietary Name: Imfinzi | Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-4611 | Proprietary Name: Imfinzi | Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0944-4622 | Proprietary Name: Adynovate | Antihemophilic Factor (recombinant) Pegylated | Kit | Takeda Pharmaceuticals Amercia, Inc. | ACTIVE | ||
0944-4623 | Proprietary Name: Adynovate | Antihemophilic Factor (recombinant) Pegylated | Kit | Takeda Pharmaceuticals Amercia, Inc. | ACTIVE | ||
0944-4624 | Proprietary Name: Adynovate | Antihemophilic Factor (recombinant) Pegylated | Kit | Takeda Pharmaceuticals Amercia, Inc. | ACTIVE | ||
0944-4625 | Proprietary Name: Adynovate | Antihemophilic Factor (recombinant) Pegylated | Kit | Takeda Pharmaceuticals Amercia, Inc. | ACTIVE | ||
0944-4626 | Proprietary Name: Adynovate | Antihemophilic Factor (recombinant) Pegylated | Kit | Takeda Pharmaceuticals Amercia, Inc. | ACTIVE | ||
0944-4627 | Proprietary Name: Adynovate | Antihemophilic Factor (recombinant) Pegylated | Kit | Takeda Pharmaceuticals Amercia, Inc. | ACTIVE | ||
0944-4628 | Proprietary Name: Adynovate | Antihemophilic Factor (recombinant) Pegylated | Kit | Takeda Pharmaceuticals Amercia, Inc. | ACTIVE | ||
0944-7551 | Proprietary Name: Vonvendi | Von Willebrand Factor (recombinant) | Kit | Takeda Pharmaceuticals America, Inc. | ACTIVE | ||
0944-7553 | Proprietary Name: Vonvendi | Von Willebrand Factor (recombinant) | Kit | Takeda Pharmaceuticals America, Inc. | ACTIVE | ||
49281-605 | Proprietary Name: Dengvaxia | Dengue Tetravalent Vaccine, Live | Kit | Sanofi Pasteur Inc. | ACTIVE | ||
50242-060 | Proprietary Name: Avastin | Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | |
50242-061 | Proprietary Name: Avastin | Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | |
50242-070 | Proprietary Name: Gazyva | Obinutuzumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | |
50242-077 | Proprietary Name: Herceptin Hylecta | Trastuzumab And Hyaluronidase-oysk | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-077 | Proprietary Name: Herceptin Hylecta | Genentech, Inc. | |||||
50242-080 | Proprietary Name: Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | |
50242-082 | Proprietary Name: Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | |
50242-108 | Proprietary Name: Rituxan Hycela | Rituximab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-109 | Proprietary Name: Rituxan Hycela | Rituximab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-132 | Proprietary Name: Herceptin | Trastuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | |
50242-150 | Proprietary Name: Ocrevus | Ocrelizumab | Injection | Intravenous | Genentech, Inc. | ACTIVE | |
50242-245 | Proprietary Name: Phesgo | Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-260 | Proprietary Name: Phesgo | Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-554 | Proprietary Name: Ocrevus Zunovo | Ocrelizumab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50881-013 | Proprietary Name: Monjuvi | Tafasitamab-cxix | Injection, Powder, Lyophilized, For Solution | Intravenous | Incyte Corporation | ACTIVE | |
51144-020 | Proprietary Name: Padcev EJFV | Enfortumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | ACTIVE | |
51144-030 | Proprietary Name: Padcev EJFV | Enfortumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | ACTIVE | |
51144-050 | Proprietary Name: Adcetris | Brentuximab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | ACTIVE | |
52658-7777 | Proprietary Name: Lymphir | Denileukin Diftitox-cxdl | Injection, Powder, Lyophilized, For Solution | Intravenous | Citius Pharmaceuticals, Inc. | ACTIVE | |
55513-056 | Proprietary Name: Pavblu | Aflibercept-ayyh | Injection, Solution | Intravitreal | Amgen, Inc | ACTIVE | |
55513-065 | Proprietary Name: Pavblu | Aflibercept-ayyh | Injection, Solution | Intravitreal | Amgen, Inc | ACTIVE | |
55513-132 | Proprietary Name: Kanjinti | Trastuzumab-anns | Injection, Powder, Lyophilized, For Solution | Intravenous | Amgen Inc | ACTIVE | |
55513-160 | Proprietary Name: Blincyto | Blinatumomab | Kit | Amgen Inc | ACTIVE | ||
55513-206 | Proprietary Name: Mvasi | Bevacizumab-awwb | Injection, Solution | Intravenous | Amgen Inc | ACTIVE | |
55513-207 | Proprietary Name: Mvasi | Bevacizumab-awwb | Injection, Solution | Intravenous | Amgen Inc | ACTIVE | |
58160-848 | Proprietary Name: Arexvy | Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted | Kit | Glaxosmithkline Biologicals Sa | ACTIVE | ||
59137-282 | Proprietary Name: Ixinity | Coagulation Factor Ix (recombinant) | Kit | Medexus Pharma, Inc. | ACTIVE | ||
59137-283 | Proprietary Name: Ixinity | Coagulation Factor Ix (recombinant) | Kit | Medexus Pharma, Inc. | ACTIVE | ||
59137-284 | Proprietary Name: Ixinity | Coagulation Factor Ix (recombinant) | Kit | Medexus Pharma, Inc. | ACTIVE | ||
59137-287 | Proprietary Name: Ixinity | Coagulation Factor Ix (recombinant) | Kit | Medexus Pharma, Inc. | ACTIVE | ||
59137-288 | Proprietary Name: Ixinity | Coagulation Factor Ix (recombinant) | Kit | Medexus Pharma, Inc. | ACTIVE | ||
59137-289 | Proprietary Name: Ixinity | Coagulation Factor Ix (recombinant) | Kit | Medexus Pharma, Inc. | ACTIVE | ||
63459-305 | Proprietary Name: Herzuma | Trastuzumab | Kit | Cephalon, Inc. | ACTIVE | ||
64406-019 | Proprietary Name: Byooviz | Ranibizumab-nuna | Injection, Solution | Intravitreal | Biogen Inc. | ACTIVE | |
65219-554 | Proprietary Name: Idacio | Adalimumab-aacf | Kit | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
65219-556 | Proprietary Name: Idacio | Adalimumab-aacf | Kit | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
65219-558 | Proprietary Name: Idacio | Adalimumab-aacf | Kit | Fresenius Kabi Usa, Llc | ACTIVE | ||
65219-612 | Proprietary Name: Adalimumab-aacf | Adalimumab | Kit | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
65857-425 | Proprietary Name: Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) | Tilmanocept | Kit | Cardinal Health 414, Llc | ACTIVE | ||
65857-450 | Proprietary Name: Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) | Tilmanocept | Kit | Cardinal Health 414, Llc | ACTIVE | ||
68727-900 | Proprietary Name: Rylaze | Asparaginase Erwinia Chrysanthemi (recombinant)-rywn | Injection | Intramuscular | Jazz Pharmaceuticals, Inc. | ACTIVE | |
69448-015 | Proprietary Name: Hercessi | Trastuzumab-strf | Injection, Powder, Lyophilized, For Solution | Intravenous | Accord Biopharma Inc. | ACTIVE | |
69448-016 | Proprietary Name: Hercessi | Trastuzumab-strf | Injection, Powder, Lyophilized, For Solution | Intravenous | Accord Biopharma Inc. | ACTIVE | |
70121-1754 | Proprietary Name: Alymsys | Bevacizumab-maly | Injection, Solution | Intravenous | Amneal Pharmaceuticals Llc | ACTIVE | |
70121-1755 | Proprietary Name: Alymsys | Bevacizumab-maly | Injection, Solution | Intravenous | Amneal Pharmaceuticals Llc | ACTIVE | |
71202-010 | Proprietary Name: Epysqli | Samsung Bioepis Co., Ltd. | |||||
71837-1000 | Proprietary Name: Bizengri | Zenocutuzumab | Injection | Intravenous | Partner Therapeutics, Inc. | ACTIVE | |
71981-001 | Proprietary Name: Oxervate | Cenegermin-bkbj | Kit | Domp� Farmaceutici S.p.a. | ACTIVE | ||
71981-020 | Proprietary Name: Oxervate | Cenegermin-bkbj | Solution/ Drops | Ophthalmic | Domp� Farmaceutici S.p.a. | ACTIVE | |
72247-101 | Proprietary Name: Curodont Repair Fluoride Plus | Credentis Ag | INACTIVATED | ||||
72247-106 | Proprietary Name: Curodont Repair Fluoride Plus | Credentis Ag | |||||
72247-108 | Proprietary Name: Curodont Repair Fluoride Plus | Sodium Fluoride | Sponge | Oral | Credentis Ag | ACTIVE | |
72606-011 | Proprietary Name: Vegzelma | Bevacizumab-adcd | Injection, Solution | Intravenous | Celltrion Usa, Inc. | ACTIVE | |
72606-012 | Proprietary Name: Vegzelma | Bevacizumab-adcd | Injection, Solution | Intravenous | Celltrion Usa, Inc. | ACTIVE | |
72677-551 | Proprietary Name: Uplizna | Inebilizumab | Injection | Intravenous | Viela Bio, Inc. | ACTIVE | |
72960-112 | Proprietary Name: Daxxify | Botulinum Toxin Type A | Injection, Powder, Lyophilized, For Solution | Intramuscular | Revance Therapeutics, Inc. | ACTIVE | |
73535-208 | Proprietary Name: Monjuvi | Tafasitamab-cxix | Injection, Powder, Lyophilized, For Solution | Intravenous | Incyte Corporation | ACTIVE | |
73606-020 | Proprietary Name: Syfovre | Pegcetacoplan | Injection, Solution | Intravitreal | Apellis Pharmaceuticals, Inc. | ACTIVE | |
75987-130 | Proprietary Name: Tepezza | Teprotumumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Horizon Therapeutics Usa, Inc. | ACTIVE | |
75987-150 | Proprietary Name: Uplizna | Inebilizumab | Injection | Intravenous | Horizon Therapeutics Usa, Inc. | ACTIVE | |
78206-147 | Proprietary Name: Ontruzant | Trastuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Organon Llc | ACTIVE | |
78206-148 | Proprietary Name: Ontruzant | Ontruzant | Kit | Intravenous | Organon Llc | ACTIVE | |
82143-001 | Proprietary Name: Avzivi tnjn | Bevacizumab | Injection, Solution | Intravenous | Bio-thera Solutions, Ltd. | ACTIVE | |
82143-002 | Proprietary Name: Avzivi | Bevacizumab-tnjn | Injection, Solution | Intravenous | Bio-thera Solutions, Ltd. | ACTIVE | |
83077-100 | Proprietary Name: Bizengri | Zenocutuzumab | Injection | Intravenous | Merus Us, Inc. | ACTIVE | |
83885-002 | Proprietary Name: Acne Scar Repair Cream | Guangzhou Guocui Biological Technology Co., Ltd | |||||
83885-007 | Proprietary Name: Acne Scar Repair Cream | Guangzhou Guocui Biological Technology Co., Ltd | |||||
84345-443 | Proprietary Name: Medical Recombinant Type Iii Humanized Collagen Repair Patch | Medical Recombinant Type Iii Humanized Collagen Repair Patch | Patch | Topical | Hunan Yinhuatang Pharmaceutical Technology Co., Ltd | ACTIVE |